Cart-19 Cells
Acute Lymphoblastic Leukemia, Adult B-Cell
The First Affiliated Hospital of Soochow UniversityCell therapyPhase 1/2Active
CC
47/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 89/ 100
Competitive context
23 Active assets in the Acute Lymphoblastic Leukemia, Adult B-Cell cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
VINCRISTINE SULFATE SWOG Cancer Research Network | Phase 3 | BBB |
PEGASPARGASE National Cancer Institute (NCI) | Phase 3 | BBB |
Cytosin-Arabinosid Massachusetts General Hospital | Phase 3 | BBB |
DEXAMETHASONE Mayo Clinic | Phase 3 | BBB |
METHOTREXATE Massachusetts General Hospital | Phase 3 | BBB |
View all 50 →
Same molecule, other indications
Cart-19 Cells is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →